Archimica and Merck KGaA seal distribution deal
Archimica has entered into an exclusive distribution agreement with a Merck KGaA subsidiary to provide building blocks and special reagents for organic synthesis.
Archimica has entered into an exclusive distribution agreement with a Merck KGaA subsidiary to provide building blocks and special reagents for organic synthesis.
Rising use of biologics and a tax initiative will drive the streamlining of Indian supply chains, helping companies to deliver drugs at affordable prices, according to PwC.
Chesapeake has acquired a leading Polish label and carton operation in a bid to expand its share of the Central and Eastern European (CEE) market.
US drugmaker Javelin Pharmaceuticals says Hospira’s takeover bid is “superior” and terminates agreement with Myriad Pharmaceuticals (MPI).
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at LAB Research, PBI, CRF Health and US Data Management.
US CRO Clinilabs has licensed NewCardio’s QTinno cardiac safety analysis software, adding ECG services to it drug industry offering.
Russia, the Ukraine and Belarus have emerged as destinations for clinical studies and now offer “enormous” potential according to US-based CRO ClinStar.
US contract pharmaceutical developer Azopharma has not yet confirmed or denied industry rumours that it has gone bankrupt.